Your browser doesn't support javascript.
loading
SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis.
van Kempen, Zoé L E; Stalman, Eileen W; Steenhuis, Maurice; Kummer, Laura Y L; van Dam, Koos P J; Wilbrink, Maarten F; Ten Brinke, Anja; van Ham, S Marieke; Kuijpers, Taco; Rispens, Theo; Eftimov, Filip; Wieske, Luuk; Killestein, Joep.
Afiliação
  • van Kempen ZLE; Neurology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands Z.vankempen@amsterdamumc.nl.
  • Stalman EW; Neurology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
  • Steenhuis M; Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands.
  • Kummer LYL; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, the Netherlands.
  • van Dam KPJ; Neurology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
  • Wilbrink MF; Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands.
  • Ten Brinke A; Neurology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
  • van Ham SM; Neurology, Amsterdam Neuroscience, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
  • Kuijpers T; Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands.
  • Rispens T; Amsterdam Institute for Infection and Immunity, Amsterdam, the Netherlands.
  • Eftimov F; Immunopathology, Sanquin Research and Landsteiner Laboratory, Amsterdam UMC, location VUMC, Amsterdam, The Netherlands.
  • Wieske L; Swammerdam Insitute for Life Sciences, Amsterdam UMC, Amsterdam, The Netherlands.
  • Killestein J; Pediatric Immunology, Rheumatology and Infectious Diseases, Amsterdam UMC, Location AMC, Amsterdam, The Netherlands.
J Neurol Neurosurg Psychiatry ; 94(4): 280-283, 2023 04.
Article em En | MEDLINE | ID: mdl-36564175

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Moduladores do Receptor de Esfingosina 1 Fosfato / COVID-19 / Esclerose Múltipla Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Moduladores do Receptor de Esfingosina 1 Fosfato / COVID-19 / Esclerose Múltipla Tipo de estudo: Observational_studies Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article